Abstract
Introduction: The purpose of this pilot study was to investigate the cardiovascular effects of pancuronium (PAN), vecuronium (VEC) and atracurium (ATR).
Hypothesis: ATR and VEC are not as potent in cardiovascular side effects, especially blood pressure (BP).
Methods: The Study was approved by the hospital's research advisory group. Infants (n=23) were randomized to receive either PAN 0.1 mg/kg, VEC 0.1 mg/kg or ATR 0.3 mg/kg prior to anaesthesia. The induction and maintenance procedures were standardized for all infants. The study drug was administered three minutes after induction in a double-blind fashion. A blinded observer recorded heart rate (HR) and blood pressure (BP) prior to induction, prior to study drug, and every 1 min for 5 min; then every 5 min for a total of 30 min. Statistics were by paired t-test and ANOVA. A p<0.05 was considered significant.
Results: The groups were comparable in age, post conceptual age, weight and electrolytes. PAN caused an increase over baseline in AR at 5 min (p<0.05) and a decrease in BP at 2 min (p=<0.01) which persisted till 10 min (p=0.01). For ATR, there were no significant changes.
Conclusions: This pilot study confirms that PAN causes an increase in HR and a decrease in BP in neonates. VEC may also cause a decrease in BP but ATR does not seem to affect either of these parameters. This suggests that for hemodynamic stability, ATR may be a better choice as a paralytic agent in newborns.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gray, S., Botcher, J., Buckley, D. et al. CARDIOVASCULAR EFFECTS OF NEUROMUSCULAR BLOCKAGE WITH PANCURONIUM, VECURONIUM, AND ATRACURIUM IN NEONATES. Pediatr Res 35, 272 (1994). https://doi.org/10.1203/00006450-199402000-00106
Issue date:
DOI: https://doi.org/10.1203/00006450-199402000-00106
